Travere Therapeutics, Inc. Common Stock
Symbol: TVTX (NASDAQ)
26.95
▲ (24.51%) 5.305
Company Description:
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.
Key Stats
- Today's Open: $25.31
- Today's High: $28.641
- Today's Low: $21.377
- Today's Volume: 12.50M
- Yesterday Close: $21.64
- Yesterday High: $21.665
- Yesterday Low: $20.84
- Yesterday Volume: 1.81M
- Last Min Volume: 104
- Last Min High: $26.945
- Last Min Low: $26.945
- Last Min VWAP: $26.945
Company Profile
- Name: Travere Therapeutics, Inc. Common Stock
- Website: https://www.travere.com
- Listed Date: 2003-07-23
- Location: SAN DIEGO, CA
- Market Status: Active
- CIK Number: 0001438533
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $1.89B
- Round Lot: 100
- Outstanding Shares: 89.14M
- Asset Type: CS
RECENT FILINGS FOR TVTX
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-10 | 8-K | View |
| 2025-09-05 | 4 | View |
| 2025-08-28 | 4 | View |
| 2025-08-15 | SCHEDULE 13G/A | View |
| 2025-08-07 | SCHEDULE 13G/A | View |
| 2025-08-06 | 10-Q | View |
| 2025-08-06 | 8-K | View |
| 2025-07-29 | SCHEDULE 13G/A | View |
| 2025-07-02 | 4 | View |
| 2025-06-17 | S-8 | View |
| 2025-05-16 | 4 | View |
| 2025-05-16 | 4 | View |
| 2025-05-16 | 4 | View |
| 2025-05-16 | 4 | View |
| 2025-05-16 | 4 | View |
| 2025-05-16 | 4 | View |
| 2025-05-16 | 4 | View |
| 2025-05-16 | 4 | View |
| 2025-05-16 | 4 | View |
| 2025-05-16 | 8-K | View |
Latest News on TVTX